CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 5,000 shares (grant or award)
- 4 Grant or award VP, CFO AND SECRETARY acquired 5,000 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 5,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award PRES./CHIEF SCIENTIFIC OFFICER acquired 5,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- SC 13D Stake Beneficial Ownership Report
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure · Other events
- 424B5 Offering Prospectus
Page 19 of 46 · 909 filings